Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pentoxifylline

C P Samlaska1, E A Winfield

  • 1Dermatology Service, Tripler Army Medical Center, Honolulu, Hawaii.

Journal of the American Academy of Dermatology
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Pentoxifylline, a hemorrheologic agent, modulates immune responses and improves hypercoagulable states. This methylxanthine derivative shows potential for treating diverse conditions beyond intermittent claudication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.

The British journal of radiology·2003
Same author

Hypertrophic toe in a 44-year-old man.

Archives of dermatology·2001
Same author

Septic embolization arising from infected pseudoaneurysms following percutaneous transluminal coronary angioplasty: a report of 2 cases and review of the literature.

Cutis·2001
Same author

Recurrent aphthous stomatitis.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics·1996
Same author

Subcutaneous emphysema.

Advances in dermatology·1996
Same author

Pyoderma gangrenosum and cranial osteolysis: case report and review of the paediatric literature.

The British journal of dermatology·1995
Same journal

Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026
Same journal

Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Pharmacology
  • Cellular Biology
  • Immunology

Background:

  • Pentoxifylline is a methylxanthine derivative known for hemorrheologic properties.
  • Currently marketed for intermittent claudication treatment in the US.
  • Exhibits diverse cellular-level physiological effects.

Purpose of the Study:

  • To review the potential medical uses of pentoxifylline.
  • To explore its effects on immune modulation, hypercoagulable states, and connective tissue disorders.

Main Methods:

  • Review of human and animal studies on pentoxifylline therapy.
  • Analysis of cellular and molecular changes induced by pentoxifylline.

Main Results:

  • Immune modulation: increased leukocyte deformability, decreased inflammatory mediator production (e.g., tumor necrosis factor), and suppressed lymphocyte activation.

Related Experiment Videos

  • Hypercoagulable states: improved by decreased platelet aggregation, increased fibrinolysis, and reduced coagulation factors.
  • Connective tissue: potential benefits in wound healing via altered fibroblast activity and extracellular matrix production.
  • Conclusions:

    • Pentoxifylline demonstrates broad therapeutic potential due to its multifaceted cellular effects.
    • Its hemorrheologic, immunomodulatory, and anti-inflammatory properties suggest utility in various human diseases.
    • Further research into these diverse applications is warranted.